Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the UK / NCT04496518
Active, not recruiting Observational

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

NCT04496518 · tracked via the Priya Life Science UK tracker
Sponsor
Medtronic
Phase
Observational
Started
2020-08-01
Last updated
2025-10-20

Condition(s) studied

Ventricular Tachycardia

Investigational drug(s) / intervention(s)

Intrinsic Antitachycardia Pacing (iATP) Therapy

Intrinsic Antitachycardia Pacing (iATP) Therapy: iATP is a fully automated ATP therapy for monomorphic ventricular tachycardia (MVT).

Study summary

Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices.

The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Patient is intended to receive or is implanted with an iATP-capable device with iATP on in any zone with ventricular ATP therapies programmed. * Patient is enrolled in the CareLink network for remote device monitoring Exclusion Criteria: * Patient who is, or is expected to be inaccessible for follow-up * Patient with exclusion criteria required by local law * Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Primary outcome measure(s)

  • To demonstrate the success rate of iATP in the fast VT (FVT) zone is greater than 60% — Approximately 5 years
    Demonstrating success rate of iATP

Trial sites (92)

FacilityCityRegionStatus
Southwest EP Chandler Arizona
Saint Vincent Heart Clinic Arkansas Little Rock Arkansas
Chula Vista Cardiac Center Chula Vista California
Cardiovascular Consultants Medical Group (Van Nuys CA) Van Nuys California
Cardiology Associates Medical Group Ventura California
Colorado Springs Cardiology Colorado Springs Colorado
Denver Heart Denver Colorado
Colorado Heart and Vascular, PC Lakewood Colorado
Hartford Hospital Hartford Connecticut
Yale New Haven Hospital New Haven Connecticut
Heart Rhythm Solutions Hollywood Florida
Baptist Health Jacksonville Florida
Cardiovascular Institute of Northwest Florida Panama City Florida
Heart & Vascular Institute of Florida Safety Harbor Florida
Heart Rhythm Consultants P.A. (Sarasota Memorial Research) Sarasota Florida
Deaconess Specialty Physicians Evansville Indiana
Iowa Heart Center (West Des Moines IA) Des Moines Iowa
The University of Kansas Medical Center Kansas City Kansas
Norton Heart and Vascular Institute Louisville Kentucky
Tidal Health Peninsula Regional Salisbury Maryland
Associates in Cardiology PA Silver Spring Maryland
Brigham and Women's Hospital (Boston MA) Boston Massachusetts
Sparrow Clinical Research Institute Lansing Michigan
Michigan Heart Ypsilanti Michigan
Mayo Clinic (Rochester MN) Rochester Minnesota
Missouri Cardiovascular Specialists Columbia Missouri
University Hospital (Columbia MO) Columbia Missouri
Saint Lukes Health System Kansas City Missouri
Washington University School of Medicine St Louis Missouri
Nebraska Medicine Omaha Nebraska
Monmouth Cardiology Associates Ocean City New Jersey
Presbyterian Heart Group Albuquerque New Mexico
South Shore University Hospital Bay Shore New York
Huntington Hospital Huntington New York
North Shore University Hospital Manhasset New York
Northern Westchester Hospital Mount Kisco New York
Long Island Jewish Medical Center New Hyde Park New York
New York-Presbyterian Hospital/Weill Cornell Medical Center New York New York
NewYork-Presbyterian/Columbia University Irving Medical Center New York New York
Lenox Hill Hospital New York New York

+ 52 more sites — see the full list on the official registry below.

More Medtronic trials in the UK

Product Surveillance Registry Recruiting
Lead Evaluation for Defibrillation and Reliability Post Approval Study Enrolling by invitation
Enlighten Study: The EV-ICD Post Approval Registry Active, not recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products Recruiting
Micra Transcatheter Pacing System Post-Approval Registry Active, not recruiting

Other trials for the same condition

VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04496518 on ClinicalTrials.gov ↗ ← All trials in the UK